13O_PR Translational Studies Within the Tamrad Randomized Gineco Trial: Evidence for Torc1 Activation Marker as a Predictive Factor for Everolimus Efficacy in Metastatic Breast Cancer (MBC)
Titel:
13O_PR Translational Studies Within the Tamrad Randomized Gineco Trial: Evidence for Torc1 Activation Marker as a Predictive Factor for Everolimus Efficacy in Metastatic Breast Cancer (MBC)
Auteur:
Bachelot, T. Ferrero, J. Cropet, C. Bourgier, C. Abadie-Lacourtoisie, S. Levy, C. Legouffe, E. Lortholary, A. Pujade-Lauraine, E. Treilleux, I.